Insider Selling: Hinge Health (NYSE:HNGE) CFO Sells 781 Shares of Stock

Hinge Health Inc. (NYSE:HNGE) CFO James Budge sold 781 shares of the firm’s stock in a transaction on Wednesday, May 20th. The stock was sold at an average price of $55.34, for a total value of $43,220.54. Following the completion of the transaction, the chief financial officer directly owned 451,293 shares of the company’s stock, valued at approximately $24,974,554.62. This trade represents a 0.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

James Budge also recently made the following trade(s):

• On Monday, May 11th, James Budge sold 5,906 shares of Hinge Health stock. The stock was sold at an average price of $54.82, for a total value of $323,766.92.
• On Monday, March 23rd, James Budge sold 11,006 shares of Hinge Health stock. The stock was sold at an average price of $42.26, for a total value of $465,113.56.

Hinge Health Stock Up 0.7%

Hinge Health stock traded up $0.37 during mid-day trading on Thursday, hitting $55.11. 1,101,431 shares of the company were exchanged, compared to its average volume of 1,259,108. The business has a fifty day moving average of $44.66 and a 200 day moving average of $44.32. Hinge Health Inc. has a 1-year low of $30.08 and a 1-year high of $62.18. The company has a market capitalization of $4.26 billion and a PE ratio of -4.47.

Hinge Health (NYSE:HNGE) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.12 by $0.33. Hinge Health had a negative return on equity of 310.62% and a negative net margin of 78.95%.The firm had revenue of $182.31 million during the quarter. During the same quarter in the prior year, the company earned $1.30 earnings per share. The business’s revenue was up 47.2% compared to the same quarter last year. Research analysts expect that Hinge Health Inc. will post 1.21 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on HNGE shares. Piper Sandler reiterated an “overweight” rating and set a $95.00 price objective on shares of Hinge Health in a research note on Wednesday, May 6th. Weiss Ratings upgraded Hinge Health from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, May 6th. Needham & Company LLC raised their target price on Hinge Health from $59.00 to $63.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. Wall Street Zen upgraded Hinge Health from a “hold” rating to a “buy” rating in a research note on Sunday, May 10th. Finally, Freedom Capital upgraded Hinge Health to a “strong-buy” rating in a research note on Thursday, January 22nd. Two analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $67.40.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. California State Teachers Retirement System lifted its holdings in Hinge Health by 35.2% during the 1st quarter. California State Teachers Retirement System now owns 19,141 shares of the company’s stock worth $738,000 after buying an additional 4,986 shares in the last quarter. Estuary Capital Management LP acquired a new position in Hinge Health during the 1st quarter worth $15,201,000. Lazard Asset Management LLC lifted its holdings in Hinge Health by 0.6% during the 1st quarter. Lazard Asset Management LLC now owns 63,705 shares of the company’s stock worth $2,456,000 after buying an additional 386 shares in the last quarter. Entropy Technologies LP lifted its holdings in Hinge Health by 28.1% during the 1st quarter. Entropy Technologies LP now owns 11,749 shares of the company’s stock worth $453,000 after buying an additional 2,579 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership increased its position in Hinge Health by 225.7% in the first quarter. Arrowstreet Capital Limited Partnership now owns 1,163,187 shares of the company’s stock worth $44,852,000 after purchasing an additional 806,007 shares during the period.

Hinge Health Company Profile

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.